CDMOs Gear Up to Churn Out Cell and Gene Therapies genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Continuous Processes: Keeping Them Safe from Viruses
Sponsored Content by Pall CorporationMay 21 2021
Virus safety is a crucial part of biopharmaceutical manufacturing. There are intrinsic risks related to virus safety in the handling of animal cell culture. Chinese Hamster Ovary (CHO) cell lines are the most frequently found production platform for expressing glycosylated proteins and monoclonal antibodies.
Image credit: Pall Corporation
Due to their rodent origins, CHO cell lines can harbor endogenous retroviruses or retrovirus-like particles. Additional virus safety risks arise from the potentiality that the cell culture could be compromised by adventitious viruses.
Consequently, the regulatory expectation for manufacturing platforms is to demonstrate the capacity to eliminate or inactivate a broad range of viruses to limit the impact of viruses on the safety of patients.
Using Stirred Tank Bioreactors for Upstream Flexibility
Sponsored Content by Pall CorporationMay 21 2021
When utilized in respect of upstream biopharmaceutical manufacturing, flexibility denotes the simplicity of setting up, scaling up, and switching between batches and various processes.
Image credit: Pall Corporation
Outstanding and enhanced flexibility is one of many key advantages of single-use systems (SUSs) and a primary reason why the adoption rate of SUS is so high. The more flexible single-use systems mean that processes can be developed and delivered a lot faster than stainless steel-based facilities.
This element is of vital importance in the global context of the race for a vaccine against COVID-19, which necessitates an industry-wide effort to hasten the development of vaccine candidates and to fundamentally support the accelerated manufacture of the billions of doses required for clinical trials and vaccination programs around the world.
Read more about India seeks investments from US companies in pharma, medical devices sector on Business Standard. India has reached out to top American pharma companies seeking investment in the country s pharmaceutical and medical devices sector
India reaches out to US companies over investment in pharma, medical devices sector
PTI
Washington |
Updated on
Ambassador to US, Taranjit Singh Sandhu, holds virtual meetings with CEOs
India has reached out to top American pharma companies seeking investment in the country’s pharmaceutical and medical devices sector, which gains urgency in view of the devastating second wave of the coronavirus pandemic. India’s Ambassador to the US, Taranjit Singh Sandhu, has held virtual meetings with Alberta Bourla, the CEO of Pfizer, Thermo Fisher CEO Marc Casper, Bernd Brust, the chairman and CEO of Antylia Scientific, and Joseph Repp, the CEO of Pall Life Sciences.